Man Group Portfolio holdings
AUM
$62.7B
Turnover
25.36%
1-Year Est. Return
29.77%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+29.77%
3 Year Est. Return
+99.46%
5 Year Est. Return
+125.78%
10 Year Est. Return
–
AUM
$55.1B
AUM Growth
-$3.71B
(-6.3%)
Cap. Flow
-$2.01B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
15.88%
Holding
2,628
New
414
Increased
1,064
Reduced
775
Closed
261
Avg Time Held Equity + Options
1.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$185M |
| 2 |
PepsiCo
PEP
|
+$176M |
| 3 |
TE Connectivity
TEL
|
+$166M |
| 4 |
Ford
F
|
+$131M |
| 5 |
3M
MMM
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$418M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$352M |
| 3 |
Amazon
AMZN
|
+$296M |
| 4 |
NVIDIA
NVDA
|
+$237M |
| 5 |
Eaton
ETN
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.85% |
| 2 | Miscellaneous | 14.37% |
| 3 | Financials | 10.33% |
| 4 | Healthcare | 9.99% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2026
Steven Madden
SHOO
$3.27B
| $455K | ﹤0.01% |
+13,411
| New | +$519K |
2026 Q1
0 quarters
|
|
2027
GFL Environmental
GFL
$18.7B
| $452K | ﹤0.01% |
10,832
+3,110
| +40% | +$133K |
2025 Q4
1 quarter
|
|
2028
Innovex International
INVX
$1.95B
| $452K | ﹤0.01% |
+18,527
| New | +$465K |
2026 Q1
0 quarters
|
|
2029
LENSAR
LNSR
$75.1M
| $447K | ﹤0.01% |
+75,056
| New | +$815K |
2026 Q1
0 quarters
|
|
2030
EPAM Systems
EPAM
$5.91B
| $446K | ﹤0.01% |
3,294
+1,794
| +120% | +$307K |
2023 Q4
9 quarters
|
|
2031
Matrix Service
MTRX
$283M
| $446K | ﹤0.01% |
38,821
-17,108
| -31% | -$204K |
2025 Q4
1 quarter
|
|
2032
Legend Biotech
LEGN
$3.7B
| $445K | ﹤0.01% |
24,604
-37,100
| -60% | -$707K |
2025 Q2
3 quarters
|
|
2033
Ferrovial N.V. Ordinary Shares
FER
$36.1B
| $441K | ﹤0.01% |
6,842
-6,043
| -47% | -$407K |
2025 Q4
1 quarter
|
|
2034
Freshpet
FRPT
$3.27B
| $438K | ﹤0.01% |
7,433
-89,282
| -92% | -$6.27M |
2023 Q3
10 quarters
|
|
2035
Booz Allen Hamilton
BAH
$8.64B
| $433K | ﹤0.01% |
5,548
-21,329
| -79% | -$1.8M |
2023 Q4
9 quarters
|
|
2036
Jack in the Box
JACK
$226M
| $431K | ﹤0.01% |
+44,559
| New | +$788K |
2026 Q1
0 quarters
|
|
2037
Unitil
UTL
$970M
| $425K | ﹤0.01% |
+8,132
| New | +$417K |
2026 Q1
0 quarters
|
|
2038
Alpha Metallurgical Resources
AMR
$2.21B
| $424K | ﹤0.01% |
+2,067
| New | +$419K |
2026 Q1
0 quarters
|
|
2039
State Street SPDR S&P Biotech ETF
XBI
$9.71B
| $418K | ﹤0.01% |
+3,270
| New | +$408K |
2026 Q1
0 quarters
|
|
2040
Bentley Systems
BSY
$10.6B
| $417K | ﹤0.01% |
11,866
-116,820
| -91% | -$4.29M |
2024 Q4
5 quarters
|
|
2041
Monte Rosa Therapeutics
GLUE
$839M
| $416K | ﹤0.01% |
25,262
+8,950
| +55% | +$171K |
2025 Q2
3 quarters
|
|
2042
Miami International Holdings
MIAX
$2.95B
| $415K | ﹤0.01% |
+10,674
| New | +$440K |
2026 Q1
0 quarters
|
|
2043
CALL
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
| $414K | ﹤0.01% |
+3,800
| New | +$444K |
2026 Q1
0 quarters
|
|
|
2044
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
| $414K | ﹤0.01% |
+3,800
| New | +$444K |
2026 Q1
0 quarters
|
|
2045
Atlanticus Holdings
ATLC
$1.38B
| $414K | ﹤0.01% |
7,888
+4,748
| +151% | +$266K |
2025 Q2
3 quarters
|
|
2046
CALL
Global Payments
GPN
$21.4B
| $404K | ﹤0.01% |
+6,000
| New | +$443K |
2026 Q1
0 quarters
|
|
|
2047
PUT
Global Payments
GPN
$21.4B
| $404K | ﹤0.01% |
+6,000
| New | +$443K |
2026 Q1
0 quarters
|
|
2048
1st Source
SRCE
$2.03B
| $403K | ﹤0.01% |
5,821
-6,112
| -51% | -$412K |
2025 Q1
4 quarters
|
|
2049
Altimmune
ALT
$449M
| $400K | ﹤0.01% |
129,846
+110,910
| +586% | +$471K |
2025 Q4
1 quarter
|
|
2050
Phoenix Education Partners
PXED
$858M
| $397K | ﹤0.01% |
+12,629
| New | +$377K |
2026 Q1
0 quarters
|
|
Similar funds
NC
Man Group's Q1 2026 Portfolio in Review
As of Q1 2026, Man Group held 2,628 positions worth $55.1B, down 6.3% from $58.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Man Group withdrew a net $2.01B in Q1 2026, closing 261 positions and reducing 775 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Man Group opened a new position in AstraZeneca worth $122M.
- Man Group's largest Q1 2026 buy was AstraZeneca: 628,476 shares worth $122M.
- Man Group added most to HDFC Bank in Q1 2026, an estimated $185M increase.
- Man Group's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $352M.
- Man Group fully exited State Street SPDR S&P 500 ETF Trust in Q1 2026, selling an estimated $418M.
- Man Group's ten largest holdings make up 16% of its $55.1B portfolio in Q1 2026.
- Man Group opened 414 new positions and closed 261 in Q1 2026.
- Man Group's portfolio value fell 6.3% quarter-over-quarter to $55.1B.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.